Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Glanbia ( (GLAPF) ) is now available.
Glanbia reported a robust start to 2026, with like-for-like group revenue up 7.2% in the first quarter on the back of 8.2% volume growth across all three business segments, partly offset by lower pricing. Performance Nutrition led the improvement with 11.5% like-for-like revenue growth driven by its Optimum Nutrition brand, while Health & Nutrition and Dairy Nutrition also delivered solid volume gains, helping push full-year adjusted EPS guidance to the upper end of the company’s medium-term range.
Health & Nutrition posted 11.6% like-for-like revenue growth supported by strong demand in EMEA and ASPAC and capacity expansions in the U.S., China and Europe, despite pass-through price declines. Dairy Nutrition revenue rose 2.0% as double-digit volume growth in high-end whey protein solutions offset weaker cheese pricing, and Glanbia underscored its balance sheet strength while returning €22.2 million to shareholders via buybacks and confirming improved segment-level revenue and EBITDA expectations for 2026.
More about Glanbia
Glanbia plc, branded as the Better Nutrition company, operates globally in performance nutrition, health and nutrition solutions, and dairy nutrition. Its portfolio includes branded sports and active nutrition products, high-quality whey proteins, functional protein solutions and bioactives, with a focus on high-growth end-use markets such as active nutrition, functional beverages and vitamins, minerals and supplements.
For an in-depth examination of GLAPF stock, go to TipRanks’ Overview page.